We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.72%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$418M
AUM Growth
+$15.7M
(+3.9%)
Cap. Flow
+$2.3M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
29.42%
Holding
120
New
4
Increased
36
Reduced
38
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$685K |
| 2 |
ConocoPhillips
COP
|
+$543K |
| 3 |
Merck
MRK
|
+$356K |
| 4 |
D.R. Horton
DHI
|
+$298K |
| 5 |
United Parcel Service
UPS
|
+$291K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$480K |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$396K |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$357K |
| 4 |
Microsoft
MSFT
|
+$243K |
| 5 |
Yum China
YUMC
|
+$224K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.41% |
| 2 | Consumer Staples | 11.33% |
| 3 | Healthcare | 11.05% |
| 4 | Financials | 10.56% |
| 5 | Industrials | 10.4% |
Similar funds
SCV
TFP
CWM
MG
HWMG
AI
LSWM
IMA
Boston Research & Management's Q2 2025 Portfolio in Review
As of Q2 2025, Boston Research & Management held 120 positions worth $418M, up 3.9% from $403M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Boston Research & Management's Q2 2025 filing shows 4 new, 36 increased, 38 reduced and 4 closed positions. Its largest new stake was GE Vernova: 600 shares worth $317K. The largest sale was iShares Core S&P 500 ETF, an estimated $480K.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Staples and Healthcare.
- Boston Research & Management's largest Q2 2025 buy was GE Vernova: 600 shares worth $317K.
- Boston Research & Management added most to Thermo Fisher Scientific in Q2 2025, an estimated $685K increase.
- Boston Research & Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $480K.
- Boston Research & Management fully exited Yum China in Q2 2025, selling an estimated $224K.
- Boston Research & Management's ten largest holdings make up 29% of its $418M portfolio in Q2 2025.
- Boston Research & Management opened 4 new positions and closed 4 in Q2 2025.
- Boston Research & Management's portfolio value rose 3.9% quarter-over-quarter to $418M.
Based on Boston Research & Management's 13F filing for Q2 2025, filed 12 Aug 2025.